# Geospace Technologies Corp: financial statements, quarterly

GEOS · Nasdaq · CIK 1001115 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/geos.md) · [Financials](/companies/geos/financials.md) · [Filings](/companies/geos/filings.md) · [Insiders](/companies/geos/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/geos/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.3 d](/filings/0001437749-24-036050.md) | [50.0](/filings/0001437749-25-003000.md) | [24.3](/filings/0001437749-25-015711.md) | [25.9](/filings/0001437749-25-025683.md) | [35.4 d](/filings/0001437749-25-036009.md) | [37.2](/filings/0001437749-26-003977.md) | [18.0](/filings/0001437749-26-015836.md) | [24.8](/filings/0001437749-26-026485.md) | [30.7 d](/filings/0001437749-25-036009.md) | [25.6](/filings/0001437749-26-003977.md) | [19.7](/filings/0001437749-26-015836.md) | [15.8](/filings/0001437749-26-026485.md) |
| Cost of revenue | $m | [15.1 d](/filings/0001437749-24-036050.md) | [27.8](/filings/0001437749-25-003000.md) | [18.4](/filings/0001437749-25-015711.md) | [17.3](/filings/0001437749-25-025683.md) | [19.5 d](/filings/0001437749-25-036009.md) | [17.1](/filings/0001437749-26-003977.md) | [16.3](/filings/0001437749-26-015836.md) | [17.3](/filings/0001437749-26-026485.md) | [27.3 d](/filings/0001437749-25-036009.md) | [22.9](/filings/0001437749-26-003977.md) | [19.0](/filings/0001437749-26-015836.md) | [15.3](/filings/0001437749-26-026485.md) |
| Gross profit | $m | [14.2 d](/filings/0001437749-24-036050.md) | [22.2](/filings/0001437749-25-003000.md) | [5.9](/filings/0001437749-25-015711.md) | [8.5](/filings/0001437749-25-025683.md) | [15.9 d](/filings/0001437749-25-036009.md) | [20.1](/filings/0001437749-26-003977.md) | [1.7](/filings/0001437749-26-015836.md) | [7.5](/filings/0001437749-26-026485.md) | [3.5 d](/filings/0001437749-25-036009.md) | [2.7](/filings/0001437749-26-003977.md) | [0.7](/filings/0001437749-26-015836.md) | [0.5](/filings/0001437749-26-026485.md) |
| Research and development | $m | [3.8 d](/filings/0001437749-24-036050.md) | [3.6](/filings/0001437749-25-003000.md) | [3.9](/filings/0001437749-25-015711.md) | [4.0](/filings/0001437749-25-025683.md) | [4.8 d](/filings/0001437749-25-036009.md) | [4.9](/filings/0001437749-26-003977.md) | [5.2](/filings/0001437749-26-015836.md) | [4.2](/filings/0001437749-26-026485.md) | [4.5 d](/filings/0001437749-25-036009.md) | [4.5](/filings/0001437749-26-003977.md) | [4.8](/filings/0001437749-26-015836.md) | [3.9](/filings/0001437749-26-026485.md) |
| Selling, general and administrative | $m | [6.5 d](/filings/0001437749-24-036050.md) | [5.8](/filings/0001437749-25-003000.md) | [6.5](/filings/0001437749-25-015711.md) | [6.9](/filings/0001437749-25-025683.md) | [7.2 d](/filings/0001437749-25-036009.md) | [7.4](/filings/0001437749-26-003977.md) | [6.8](/filings/0001437749-26-015836.md) | [7.5](/filings/0001437749-26-026485.md) | [8.1 d](/filings/0001437749-25-036009.md) | [8.3](/filings/0001437749-26-003977.md) | [7.4](/filings/0001437749-26-015836.md) | [6.7](/filings/0001437749-26-026485.md) |
| Operating income | $m | [4.1 d](/filings/0001437749-24-036050.md) | [12.8](/filings/0001437749-25-003000.md) | [(4.5)](/filings/0001437749-25-015711.md) | [(2.4)](/filings/0001437749-25-025683.md) | [1.2 d](/filings/0001437749-25-036009.md) | [7.8](/filings/0001437749-26-003977.md) | [(10.3)](/filings/0001437749-26-015836.md) | [0.4](/filings/0001437749-26-026485.md) | [(9.2) d](/filings/0001437749-25-036009.md) | [(10.2)](/filings/0001437749-26-003977.md) | [(11.4)](/filings/0001437749-26-015836.md) | [(10.1)](/filings/0001437749-26-026485.md) |
| Interest expense | $m | [0.0 d](/filings/0001437749-24-036050.md) | [0.1](/filings/0001437749-24-003520.md) | [0.0](/filings/0001437749-24-015905.md) | [0.0](/filings/0001437749-25-025683.md) | [0.0 d](/filings/0001437749-25-036009.md) | [0.0](/filings/0001437749-26-003977.md) | [0.0](/filings/0001437749-26-015836.md) | [0.0](/filings/0001437749-26-026485.md) | [0.0 d](/filings/0001437749-25-036009.md) | [(0.0)](/filings/0001437749-26-003977.md) | [0.0](/filings/0001437749-26-015836.md) | [0.0](/filings/0001437749-26-026485.md) |
| Income tax | $m | [0.1 d](/filings/0001437749-24-036050.md) | [0.1](/filings/0001437749-25-003000.md) | [0.0](/filings/0001437749-25-015711.md) | [(0.0)](/filings/0001437749-25-025683.md) | [0.0 d](/filings/0001437749-25-036009.md) | [0.1](/filings/0001437749-26-003977.md) | [(0.1)](/filings/0001437749-26-015836.md) | [0.1](/filings/0001437749-26-026485.md) | [0.3 d](/filings/0001437749-25-036009.md) | [0.1](/filings/0001437749-26-003977.md) | [(0.0)](/filings/0001437749-26-015836.md) | [(0.0)](/filings/0001437749-26-026485.md) |
| Net income | $m | [4.4 d](/filings/0001437749-24-036050.md) | [12.7](/filings/0001437749-25-025683.md) | [(4.3)](/filings/0001437749-25-025683.md) | [(2.1)](/filings/0001437749-25-025683.md) | [(12.9) d](/filings/0001437749-25-036009.md) | [8.4](/filings/0001437749-26-026485.md) | [(9.8)](/filings/0001437749-26-026485.md) | [0.8](/filings/0001437749-26-026485.md) | [(9.1) d](/filings/0001437749-25-036009.md) | [(9.8)](/filings/0001437749-26-026485.md) | [(11.0)](/filings/0001437749-26-026485.md) | [(9.7)](/filings/0001437749-26-026485.md) |
| Diluted EPS | $ per share | not reported | [0.94](/filings/0001437749-25-003000.md) | [(0.32)](/filings/0001437749-25-015711.md) | [(0.16)](/filings/0001437749-25-025683.md) | not reported | [0.65](/filings/0001437749-26-003977.md) | [(0.77)](/filings/0001437749-26-015836.md) | [0.06](/filings/0001437749-26-026485.md) | not reported | [(0.76)](/filings/0001437749-26-003977.md) | [(0.86)](/filings/0001437749-26-015836.md) | [(0.75)](/filings/0001437749-26-026485.md) |
| Basic EPS | $ per share | not reported | [0.96](/filings/0001437749-25-003000.md) | [(0.32)](/filings/0001437749-25-015711.md) | [(0.16)](/filings/0001437749-25-025683.md) | not reported | [0.66](/filings/0001437749-26-003977.md) | [(0.77)](/filings/0001437749-26-015836.md) | [0.06](/filings/0001437749-26-026485.md) | not reported | [(0.76)](/filings/0001437749-26-003977.md) | [(0.86)](/filings/0001437749-26-015836.md) | [(0.75)](/filings/0001437749-26-026485.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.8](/filings/0001437749-24-036050.md) | [18.9](/filings/0001437749-24-003520.md) | [20.8](/filings/0001437749-24-015905.md) | [12.3](/filings/0001437749-24-025790.md) | [6.9](/filings/0001437749-25-036009.md) | [1.4](/filings/0001437749-25-003000.md) | [8.3](/filings/0001437749-25-015711.md) | [23.6](/filings/0001437749-25-025683.md) | [26.3](/filings/0001437749-26-026485.md) | [10.6](/filings/0001437749-26-003977.md) | [13.4](/filings/0001437749-26-015836.md) | [2.8](/filings/0001437749-26-026485.md) |
| Current assets | $m | [75.8](/filings/0001437749-24-036050.md) | [100.0](/filings/0001437749-24-003520.md) | [92.1](/filings/0001437749-24-015905.md) | [86.0](/filings/0001437749-24-025790.md) | [89.4](/filings/0001437749-25-036009.md) | [95.1](/filings/0001437749-25-003000.md) | [87.0](/filings/0001437749-25-015711.md) | [90.1](/filings/0001437749-25-025683.md) | [88.5](/filings/0001437749-26-026485.md) | [77.7](/filings/0001437749-26-003977.md) | [75.7](/filings/0001437749-26-015836.md) | [68.8](/filings/0001437749-26-026485.md) |
| Total assets | $m | [153](/filings/0001437749-24-036050.md) | [167](/filings/0001437749-24-003520.md) | [158](/filings/0001437749-24-015905.md) | [152](/filings/0001437749-24-025790.md) | [152](/filings/0001437749-25-036009.md) | [160](/filings/0001437749-25-003000.md) | [149](/filings/0001437749-25-015711.md) | [150](/filings/0001437749-25-025683.md) | [153](/filings/0001437749-26-026485.md) | [145](/filings/0001437749-26-003977.md) | [137](/filings/0001437749-26-015836.md) | [125](/filings/0001437749-26-026485.md) |
| Current liabilities | $m | [19.8](/filings/0001437749-24-036050.md) | [20.6](/filings/0001437749-24-003520.md) | [15.1](/filings/0001437749-24-015905.md) | [14.1](/filings/0001437749-24-025790.md) | [17.2](/filings/0001437749-25-036009.md) | [16.9](/filings/0001437749-25-003000.md) | [15.6](/filings/0001437749-25-015711.md) | [15.3](/filings/0001437749-25-025683.md) | [24.4](/filings/0001437749-26-026485.md) | [25.6](/filings/0001437749-26-003977.md) | [30.3](/filings/0001437749-26-015836.md) | [28.2](/filings/0001437749-26-026485.md) |
| Total liabilities | $m | [20.3](/filings/0001437749-24-036050.md) | [21.1](/filings/0001437749-24-003520.md) | [15.5](/filings/0001437749-24-015905.md) | [14.5](/filings/0001437749-24-025790.md) | [17.6](/filings/0001437749-25-036009.md) | [17.2](/filings/0001437749-25-003000.md) | [15.9](/filings/0001437749-25-015711.md) | [15.5](/filings/0001437749-25-025683.md) | [27.5](/filings/0001437749-26-026485.md) | [28.7](/filings/0001437749-26-003977.md) | [31.6](/filings/0001437749-26-015836.md) | [29.4](/filings/0001437749-26-026485.md) |
| Long-term debt | $m | [0.0](/filings/0001437749-24-036050.md) | [0.0](/filings/0001437749-24-003520.md) | [0.0](/filings/0001437749-24-015905.md) | not reported | [0.0](/filings/0001437749-25-036009.md) | [0.0](/filings/0001437749-26-003977.md) | not reported | not reported | [0.0](/filings/0001437749-26-026485.md) | [0.0](/filings/0001437749-26-003977.md) | [0.0](/filings/0001437749-26-015836.md) | [0.0](/filings/0001437749-26-026485.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [133](/filings/0001437749-25-036009.md) | [146](/filings/0001437749-25-025683.md) | [142](/filings/0001437749-25-025683.md) | [137](/filings/0001437749-25-025683.md) | [135](/filings/0001437749-26-026485.md) | [143](/filings/0001437749-26-026485.md) | [133](/filings/0001437749-26-026485.md) | [134](/filings/0001437749-26-026485.md) | [126](/filings/0001437749-26-026485.md) | [116](/filings/0001437749-26-026485.md) | [105](/filings/0001437749-26-026485.md) | [95.7](/filings/0001437749-26-026485.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.4 d](/filings/0001437749-24-036050.md) | [2.7](/filings/0001437749-25-003000.md) | [(8.9) d](/filings/0001437749-25-015711.md) | [(1.3) d](/filings/0001437749-25-025683.md) | [(1.6) d](/filings/0001437749-25-036009.md) | [(11.5)](/filings/0001437749-26-003977.md) | [(1.9) d](/filings/0001437749-26-015836.md) | [(4.7) d](/filings/0001437749-26-026485.md) | [(4.1) d](/filings/0001437749-25-036009.md) | [(15.1)](/filings/0001437749-26-003977.md) | [(1.6) d](/filings/0001437749-26-015836.md) | [(10.7) d](/filings/0001437749-26-026485.md) |
| Capital expenditure | $m | [2.1 d](/filings/0001437749-24-036050.md) | [0.8](/filings/0001437749-25-003000.md) | [2.4 d](/filings/0001437749-25-015711.md) | [0.4 d](/filings/0001437749-25-025683.md) | [0.3 d](/filings/0001437749-25-036009.md) | [3.2](/filings/0001437749-26-003977.md) | [1.2 d](/filings/0001437749-26-015836.md) | [1.4 d](/filings/0001437749-26-026485.md) | [2.1 d](/filings/0001437749-25-036009.md) | [2.5](/filings/0001437749-26-003977.md) | [0.5 d](/filings/0001437749-26-015836.md) | [0.3 d](/filings/0001437749-26-026485.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-036050.md) | [0.0](/filings/0001437749-25-003000.md) | [0.0 d](/filings/0001437749-25-015711.md) | [3.0 d](/filings/0001437749-25-025683.md) | [3.4 d](/filings/0001437749-25-036009.md) | [0.2](/filings/0001437749-26-003977.md) | [0.4 d](/filings/0001437749-26-015836.md) | [0.0 d](/filings/0001437749-26-026485.md) | [0.0 d](/filings/0001437749-25-036009.md) | [0.0](/filings/0001437749-26-003977.md) | [0.0 d](/filings/0001437749-26-015836.md) | [0.0 d](/filings/0001437749-26-026485.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.1](/filings/0001437749-24-003520.md) | [13.2](/filings/0001437749-24-015905.md) | [13.3](/filings/0001437749-24-025790.md) | [13.5](/filings/0001437749-25-003000.md) | [13.3](/filings/0001437749-25-015711.md) | [13.2](/filings/0001437749-25-025683.md) | [12.9](/filings/0001437749-26-003977.md) | [12.8](/filings/0001437749-26-015836.md) | [12.8](/filings/0001437749-26-026485.md) | [12.8](/filings/0001437749-26-003977.md) | [12.9](/filings/0001437749-26-015836.md) | [12.9](/filings/0001437749-26-026485.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,935,603 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026485.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.